<DOC>
	<DOCNO>NCT02594488</DOCNO>
	<brief_summary>The majority deaths myocardial infarction occur patient preserve left ventricular ejection fraction ( &gt; 35 % ) prophylactic strategy exist . Periodic Repolarization Dynamics ( PRD ) Deceleration Capacity ( DC ) heart rate autonomic risk marker identify new high risk group patient LVEF 35-50 % poor prognosis patient LVEF ≤35 % . In SMART-MI , post-infarction patient LVEF 35-50 % abnormal PRD and/or DC randomly assign biomonitoring-guided therapy conventional follow-up .</brief_summary>
	<brief_title>Implantable Cardiac Monitors High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction</brief_title>
	<detailed_description>Sudden cardiac death ( SCD ) common single cause death industrialize world . Patients myocardial infarction ( MI ) increase risk SCD . Current guideline recommend prophylactic ICD-implantation post-MI patient reduce left ventricular ejection fraction ( LVEF ≤35 % ) . However , majority arrhythmic death MI occur patient LVEF &gt; 35 % specific prophylactic strategy exist , indicate important unmet medical need . There large body evidence presence cardiac autonomic dysfunction MI associate increased susceptibility malignant brady- tachyarrhythmias eventually culminate SCD . Periodic repolarization dynamic ( PRD ) heart rate deceleration capacity ( DC ) clinically validate autonomic risk marker provide strong independent prognostic information post-MI patient LVEF &gt; 35 % . PRD DC reflect different facet autonomic function therefore use combination predict risk . Previous study demonstrate combined assessment PRD DC identify new high-risk group among post-MI patient moderately reduce LVEF ( 36-50 % ) . This new high-risk group similar characteristic respect prognosis patient number establish high-risk group identify LVEF ≤35 % . However , exact mechanism lead death new high-risk group need investigate order develop specific preventive strategy . As known study implantable cardiac monitor ( ICM ) post-MI patient LVEF ≤40 % eventual death often precede primarily asymptomatic serious arrhythmic event . These data suggest potential time frame pre-emptive intervention case arrhythmic event , could improve outcome . Therefore , SMART-MI ass occurrence prognostic implication serious arrhythmic event newly identify high-risk group remote monitor ICM . Survivors acute MI ( &lt; 40 day ) LVEF 36-50 % undergo autonomic test presence abnormal PRD and/or DC . Those autonomic dysfunction randomly assign ICM-implantation conventional follow-up . Superiority ICMs detection predefined serious arrhythmic event test base time-to-event analysis . A central ICM core lab implement allow response arrhythmia within 48h . The effect remote monitor clinical outcome test secondary endpoint . The study provide rationale future guideline-relevant study test prophylactic therapy newly identify high-risk group .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Autonomic Nervous System Diseases</mesh_term>
	<mesh_term>Primary Dysautonomias</mesh_term>
	<criteria>Acute myocardial infarction &lt; 40 day Left ventricular ejection fraction 3650 % Presence cardiac autonomic dysfunction mean abnormal periodic repolarization dynamic and/or abnormal deceleration capacity Age 1880 year Sinus rhythm Optimal medical therapy ICD pacemaker indication Known paroxysmal persistent atrial fibrillation Life expectancy &lt; 12 month Inability comply followup Pregnancy Participation another trial may interfere</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Myocardial infarction</keyword>
	<keyword>Autonomic nervous system</keyword>
	<keyword>Risk stratification</keyword>
	<keyword>Implantable cardiac monitor</keyword>
	<keyword>Sudden cardiac death</keyword>
	<keyword>ECG</keyword>
</DOC>